Buscar recursos académicos

ABSTRACT Elevated liver stiffness is closely associated with morbidity and mortality in metabolic dysfunction‐associated steatotic liver disease (MASLD). However, the contribution of increased stiffness to impaired liv...

Objective: The study evaluated the impact of low-level alcohol intake on liver health in patients with type 2 diabetes (T2DM) and metabolic dysfunction–associated steatotic liver disease (MASLD).

Background: The objective of this study was to assess how dietary iron intake relates to the risk of all-cause mortality among individuals with non-alcoholic fatty liver disease (NAFLD). Methods: The research comprised a...

Abstract Background Metabolic dysfunction-associatedsteatotic liver disease (MASLD) has become the most prevalent chronic liver disease worldwide. Its incidence continues to rise with a marked trend toward younger age gr...

ABSTRACT Bidens pilosa L. is a medicinal plant popularly used for treatment of liver diseases. In this study, the dry extract of aerial parts of Bidens pilosa and Silymarin, a phytocomplex obtained from the Silybum maria...

Abstract Background Chronic liver disease (CLD) and heart disease (HD) are major contributors to global morbidity and mortality. Although increasing evidence supports close interactions between the liver and heart, popul...

Aim. To determine the clinical features of moderate community-acquired pneumonia (CAP) associated with COVID-19 in patients without comorbidities compared to those with comorbid metabolic dysfunction-associated steatotic...

Evidence links pesticides to nonalcoholic fatty liver disease (NAFLD), but the combined effects of dietary pesticide residue mixture exposure on NAFLD remain poorly documented. This study employed a 42-day subchronic exp...

Chao Zhang,1 Zixin Zhang,2,3 Qi Qi,2,3 Lei Li,3 Jie Deng,3 Jiao Zheng,3 Yue Jiang,1 Quanle Han,3 Shouling Wu,4 Kangbo Li5 1Catheterization Unit, Tangshan Gongren Hospital, Tangshan, People’s Republic of China; 2Hebei M...

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease around the world, with at least 40% global prevalence. Although genetic susceptibility contributes to disease risk...

ِAbstract The study was designed to estimate the effect of fatty liver disease on the level of some biochemical parameters, percentage of fatty acids in serum lipids. the study includes (25) fatty liver patients as veri...

Yu Zhao,1,* Luting Wang,2,3,* Shengrui Zhu,4 Rui Feng,5 Wei Zhang1 1Geriatric Medicine Center, Department of Endocrinology, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzho...

Glycyrrhizin preparations (GLPS), derived from Glycyrrhiza uralensis (licorice), are widely used hepatoprotective agents in clinical practice. Their primary active components, 18α- and 18β-glycyrrhetinic acid (GA), are...

Aim: Chronic liver disease (CLD) is characterized by progressive impairment of hepatic function and frequent lipid metabolism abnormalities, with reductions in high-density lipoprotein cholesterol (HDL-C) and other lipop...

Abstract The integration of the multitude of ultrasound techniques into a “one-stop” liver clinic model will revolutionize the management of liver diseases. This approach streamlines patient care by providing immedia...

Abstract Objective: To verify the prevalence and factors associated with Non-Alcoholic Fatty Liver Disease (NAFLD) among women with Polycystic Ovary Syndrome (PCOS). Methods: A cross-sectional study was conducted with ...

ABSTRACT Background and Aims In liver disease (LD), multidisciplinary teams (MDTs) support complex decision‐making and may improve care delivery. The present study aims to evaluate the role of a multidisciplinary appro...

ObjectiveMetabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent condition with limited established dietary therapies. Lifestyle modifications, particularly dietary adjustments, represent the prim...

ABSTRACT Background Non‐Alcoholic Fatty Liver Disease (NAFLD) is a significant global health concern linked with metabolic syndrome, affecting approximately 25% of the global population. It leads to severe liver compli...

ABSTRACT We aimed to investigate the effects and mechanisms of tin caulis dendrobium polysaccharide on body weight and non-alcoholic fatty liver disease in Sprague-Dawleg rats. The rats were fed a high-fat diet (HFD) wit...

Interactions between communities of the gut microbiome and with the host could affect the onset and progression of metabolic associated fatty liver disease (MAFLD), and can be useful as new diagnostic and prognostic biom...

Objective: We aimed to characterise the liver tissue bacterial metataxonomic signature in two independent cohorts of patients with biopsy-proven non-alcoholic fatty liver disease (NAFLD) diagnosis, as differences in the ...

Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading cause of morbidity and mortality due to chronic liver disease. There is an extensive body of evidence focusing on pharmacotherapy...

Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis in the absence of a history of significant alcohol use or other known liver disease. Nonalcoholic steatohepatitis (NASH) is the progressive f...